단일 세포 분석 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global single-cell analysis market size is expected to reach USD 36.14 Billion in 2034 from USD 6.04 Billion in 2025, growing at a CAGR of 21.99% during 2026-2034.The global single-cell analysis market is experiencing rapid growth as researchers increasingly focus on studying individual cells to better understand biological processes and disease mechanisms. Single-cell analysis technologies allow scientists to examine genetic, protein, and metabolic characteristics at the cellular level. This approach provides valuable insights into complex biological systems that cannot be observed through traditional bulk analysis methods.

Advancements in genomics, transcriptomics, and high-throughput sequencing technologies are significantly driving market growth. These technologies enable researchers to analyze thousands of individual cells simultaneously, accelerating discoveries in areas such as cancer research, immunology, and neuroscience. Pharmaceutical and biotechnology companies are also adopting single-cell analysis to improve drug discovery and personalized medicine strategies.

In the future, the market is expected to grow as precision medicine and advanced biomedical research continue to evolve. Increasing investments in genomics research and the development of innovative analytical tools will further enhance the capabilities of single-cell technologies. As scientists continue exploring cellular diversity and disease pathways, single-cell analysis will play a critical role in advancing medical research.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Consumables
• Instruments

By Application

• Cancer
• Immunology
• Neurology
• Stem Cell
• Non-invasive Prenatal Diagnosis
• In-vitro Fertilization
• Others

By Workflow

• Single Cell Isolation & Library Preparation
• Downstream Analysis
• Data Analysis

By End-use

• Academic And Research Laboratories
• Biotechnology And Pharmaceutical Companies
• Hospitals And Diagnostic Laboratories
• Others

COMPANIES PROFILED

• 10x Genomics, Bio-Rad Laboratories, BD, Illumina, Thermo Fisher Scientific, Danaher, Standard BioTools, Parse Biosciences, Mission Bio, Fluent BioSciences, Scale Biosciences, Singular Genomics, NanoString, QIAGEN, Miltenyi Biotec, Takara Bio, Revvity, Oxford Nanopore Technologies, BGI, MGI Tech

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Stem Cell Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Non-invasive Prenatal Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. In-vitro Fertilization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Single Cell Isolation & Library Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Downstream Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Academic And Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biotechnology And Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Hospitals And Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SINGLE-CELL ANALYSIS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Workflow
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Workflow
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Spain
  • 8.3.10 Russia
  • 8.3.11 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Workflow
  • 8.4.4 By End-use
  • 8.4.5 China
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 India
  • 8.4.9 Australia
  • 8.4.10 South East Asia
  • 8.4.11 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Workflow
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Workflow
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SINGLE-CELL ANALYSIS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 10x Genomics
  • 10.2.2 Bio-Rad Laboratories
  • 10.2.3 BD
  • 10.2.4 Illumina
  • 10.2.5 Thermo Fisher Scientific
  • 10.2.6 Danaher
  • 10.2.7 Standard BioTools
  • 10.2.8 Parse Biosciences
  • 10.2.9 Mission Bio
  • 10.2.10 Fluent BioSciences
  • 10.2.11 Scale Biosciences
  • 10.2.12 Singular Genomics
  • 10.2.13 NanoString
  • 10.2.14 QIAGEN
  • 10.2.15 Miltenyi Biotec
  • 10.2.16 Takara Bio
  • 10.2.17 Revvity
  • 10.2.18 Oxford Nanopore Technologies
  • 10.2.19 BGI
  • 10.2.20 MGI Tech